Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.660
+0.165 (3.67%)
At close: Aug 21, 2026, 4:00 PM EDT
4.669
+0.009 (0.19%)
After-hours: Aug 21, 2026, 7:57 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $584.88 million as of August 21, 2026. Its market cap has increased by 51.17% in one year.
Market Cap
584.88M
Enterprise Value
545.43M
1-Year Change
51.17%
Ranking
Category
Stock Price
$4.66
ChartMarket Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $385.20M to $584.88M, an increase of 51.84%. That is a compound annual growth rate of 5.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 584.90M | -25.78% |
| Dec 31, 2025 | 788.10M | 142.79% |
| Dec 31, 2024 | 324.60M | 140.62% |
| Dec 29, 2023 | 134.90M | 176.43% |
| Dec 30, 2022 | 48.80M | -68.76% |
| Dec 31, 2021 | 156.20M | -13.17% |
| Dec 31, 2020 | 179.90M | 23.39% |
| Dec 31, 2019 | 145.80M | -7.19% |
| Dec 31, 2018 | 157.10M | -59.22% |
| Jul 25, 2018 | 385.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 922.63M |
| Amphastar Pharmaceuticals | 918.82M |
| Collegium Pharmaceutical | 882.58M |
| Ironwood Pharmaceuticals | 708.88M |
| Evotec SE | 696.39M |
| Tilray Brands | 656.37M |
| Evolus | 554.16M |
| Kamada | 465.10M |